AthleteNCT07546513
Effects of Cistanche Supplementation on Anaerobic Exercise Performance and Recovery in Men With Different Athletic Training Levels
A study testing Cistanche deserticola and Standardized anaerobic training program in people with Athlete and Elite Athlete, run by Beijing Sport University at 1 site in China.
Trial summary
This study is a double-blind, randomized, placebo-controlled trial designed to examine whether 8 weeks of Cistanche deserticola supplementation, when combined with a standardized anaerobic training program, can improve anaerobic exercise performance, recovery, and selected body composition outcomes in young adult men… Read more about this study
- Who is it for?
- Ages 18 to 25 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Athlete, Elite Athlete, Sport Performance
- What is being tested?
- Cistanche deserticola and Standardized anaerobic training program
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 56 participants
- Where
- 1 siteChina
- Study dates
- 25 Jun 2026to 15 Sep 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Male, aged 18 to 25 years
- Body mass index (BMI) between 18.5 and 25.0 kg/m²
- Able and willing to provide written informed consent
- Willing to comply with study procedures, supplementation, training, and assessments
- Belonging to one of the following athletic training strata:
- High-level elite stratum: Chinese National Level-1 Athlete standard in sprint-related events, regular training in past 12 months and active during study
- Amateur stratum: regular exercise-training background in past 12 months without National Level-1 status
Who cannot join
- Use of steroids or ergogenic supplements during study
- Known cardiovascular, metabolic, musculoskeletal, or other conditions making participation unsafe or affecting outcomes
- Current use of medications affecting muscle growth, recovery, hormones, or high-intensity performance
- Current injury or limitation preventing safe participation
- Known allergy or intolerance to supplement/placebo ingredients
- Participation in another clinical trial or structured intervention during study period
- Inability or unwillingness to comply with protocol
- Any other condition deemed unsuitable by investigators
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Cistanche Supplementation on Anaerobic Exercise Performance and Recovery in Men With Different Athletic Training Levels: A Double-Blind, Randomized, Placebo-Controlled Trial
This study is a double-blind, randomized, placebo-controlled trial designed to examine whether 8 weeks of Cistanche deserticola supplementation, when combined with a standardized anaerobic training program, can improve anaerobic exercise performance, recovery, and selected body composition outcomes in young adult men with different athletic training levels.
Participants will be assigned to receive either Cistanche deserticola extract or a matched placebo while completing the same supervised anaerobic training program. The study will assess changes in anaerobic performance, including Wingate test outcomes and jump performance, as well as recovery-related indicators such as blood lactate, creatine kinase, malondialdehyde, testosterone, cortisol, and the testosterone-to-cortisol ratio. Body composition outcomes, including body fat percentage and skeletal muscle mass, will also be evaluated.
The purpose of this study is to determine whether Cistanche deserticola supplementation provides additional benefits beyond training alone, and whether these effects differ between highly trained and recreationally trained participants.
- Conditions
- Athlete, Elite Athlete, Sport Performance, Exercise Recovery
- Being tested
- Cistanche deserticola, Matched placebo paste, Standardized anaerobic training program
- Keywords
- Cistanche, anaerobic performance, exercise recovery, explosive power, lactate, muscle damage, body composition, randomized controlled trial
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cistanche deserticolaDietary supplement
Participants receive Cistanche deserticola extract paste at a dose of 5 g/day for 8 weeks. The supplement is administered in two sachets per day, one after breakfast and one after lunch. The product is derived from Cistanche deserticola Y.C. Ma cultivated in Inner Mongolia and consists primarily of phenylethanoid glycosides. Batch-specific quality-control documentation is provided by the supplier to ensure consistency.
Matched placebo pasteDietary supplement
Participants receive a matched placebo for 8 weeks. The placebo is administered in two sachets per day, one after breakfast and one after lunch, following the same schedule as the experimental supplement. It contains maltodextrin, microcrystalline cellulose, caramel coloring, and a food-grade bittering agent, and is matched to the active supplement in appearance, weight, texture, and taste.
Standardized anaerobic training programBehavioural
All participants complete the same supervised standardized anaerobic training program 3 times per week for 8 consecutive weeks. Each session lasts approximately 50 to 65 minutes and includes a dynamic warm-up, repeated sprint training, explosive/strength-support exercises, short-bout high-intensity interval training, and a cool-down. Training load is progressively increased across the intervention period, and attendance as well as session rating of perceived exertion are recorded throughout the study.
| Study group | Role | What they receive |
|---|---|---|
| Cistanche Supplementation + Standardized Anaerobic Training | Experimental | Participants in this arm receive Cistanche deserticola extract paste (5 g/day) for 8 weeks while completing the same supervised standardized anaerobic training program as the control arm. The training program is performed 3 times per week and includes repeated sprint training, explosive/strength-support exercises, and short-bout high-intensity interval training. Receives: Dietary Supplement: Cistanche deserticola; Behavioral: Standardized anaerobic training program |
| Placebo + Standardized Anaerobic Training | Active comparator | Participants in this arm receive a matched placebo for 8 weeks while completing the same supervised standardized anaerobic training program as the experimental arm. The placebo is matched in appearance, weight, texture, and taste. The training program is performed 3 times per week and includes repeated sprint training, explosive/strength-support exercises, and short-bout high-intensity interval training. Receives: Dietary Supplement: Matched placebo paste; Behavioral: Standardized anaerobic training program |
What is being measured
The primary outcome is the main question the study is designed to answer.
Peak power during the 30-second Wingate Anaerobic Test
Peak power (W) measured during a 30-second Wingate Anaerobic Test performed on a Monark 894E cycle ergometer. The test is conducted under standardized conditions, and the primary analysis will evaluate the change from baseline to post-intervention and the between-group difference in change after 8 weeks of intervention.
Measured: Baseline (week 0) and post-intervention (week 8)
Squat jump height
Squat jump (SJ) height in centimeters, assessed under standardized testing conditions as a measure of lower-limb explosive performance. Analyses will assess change from baseline to post-intervention and between-group differences in change.
Measured: Baseline (week 0) and post-intervention (week 8)
Countermovement jump
Countermovement jump (CMJ) height in centimeters, assessed under standardized testing conditions as a measure of lower-limb explosive performance. Analyses will assess change from baseline to post-intervention and between-group differences in change.
Measured: Baseline (week 0) and post-intervention (week 8)
Secondary outcomes (10)
Average power during the 30-second Wingate Anaerobic Test
Average power (W) measured during the 30-second Wingate Anaerobic Test. Analyses will assess change from baseline to post-intervention and between-group differences in change.
Measured: Baseline (week 0) and post-intervention (week 8)
Minimum power during the 30-second Wingate Anaerobic Test
Measured: Baseline (week 0) and post-intervention (week 8)
Power drop during the 30-second Wingate Anaerobic Test
Power drop (%) calculated from the 30-second Wingate Anaerobic Test as an index of fatigue during maximal anaerobic effort. Analyses will assess change from baseline to post-intervention and between-group differences in change.
Measured: Baseline (week 0) and post-intervention (week 8)
Post-exercise blood lactate response
Capillary blood lactate concentration (mmol/L) measured immediately after the Wingate Anaerobic Test and at 3 minutes of recovery as indices of acute metabolic stress and recovery. Analyses will assess change from baseline to post-intervention and between-group differences in change.
Measured: Baseline (week 0) and post-intervention (week 8)
Serum creatine kinase concentration
Measured: Baseline (week 0) and post-intervention (week 8)
Serum malondialdehyde concentration
Serum malondialdehyde (MDA, nmol/mL) measured as a biomarker related to oxidative stress. Analyses will assess change from baseline to post-intervention and between-group differences in change.
Measured: Baseline (week 0) and post-intervention (week 8)
Serum testosterone concentration
Fasting serum testosterone concentration (ng/mL) measured from venous blood samples collected under standardized morning conditions.
Measured: Baseline (week 0) and post-intervention (week 8)
Body fat percentage
Body fat percentage measured using bioelectrical impedance analysis (InBody 770). Analyses will assess change from baseline to post-intervention and between-group differences in change.
Measured: Baseline (week 0) and post-intervention (week 8)
Skeletal muscle mass
Skeletal muscle mass (kg) measured using bioelectrical impedance analysis (InBody 770). Analyses will assess change from baseline to post-intervention and between-group differences in change.
Measured: Baseline (week 0) and post-intervention (week 8)
Serum cortisol concentration
Fasting serum cortisol concentration (μg/dL) measured from venous blood samples collected under standardized morning conditions.
Measured: Baseline (week 0) and post-intervention (week 8)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Apr 2026
- Study start25 Jun 2026
- Primary completion1 Sep 2026
- Study completion15 Sep 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (15)Papers the sponsor has linked to this study.
- Other trials for AthleteStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Model Description
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 56 participants (actual)
Sponsor and investigators
- Lead sponsor
- Beijing Sport University
- Sponsor type
- University, hospital or other
- Collaborators
- Wuhan Sports University
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07546513
- Sponsor's protocol ID
- 2025161
- Status last verified
- Jun 2026
- First submitted
- 13 Apr 2026
- Last updated
- 21 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: The investigators have not yet decided whether individual participant data will be shared. Any future sharing of de-identified data will depend on participant consent, institutional requirements, ethics approval, and data governance considerations.
Publications
Bassett DR Jr. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1396. doi: 10.1249/01.MSS.0000078923.96621.1D. No abstract available.
PubMed 12900695Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci. 2002 Oct;57(10):B359-65. doi: 10.1093/gerona/57.10.b359.
PubMed 12242311Foster C, Florhaug JA, Franklin J, Gottschall L, Hrovatin LA, Parker S, Doleshal P, Dodge C. A new approach to monitoring exercise training. J Strength Cond Res. 2001 Feb;15(1):109-15.
PubMed 11708692Bobbert MF, Gerritsen KG, Litjens MC, Van Soest AJ. Why is countermovement jump height greater than squat jump height? Med Sci Sports Exerc. 1996 Nov;28(11):1402-12. doi: 10.1097/00005768-199611000-00009.
PubMed 8933491Thomas S, Reading J, Shephard RJ. Revision of the Physical Activity Readiness Questionnaire (PAR-Q). Can J Sport Sci. 1992 Dec;17(4):338-45.
PubMed 1330274Adlercreutz H, Harkonen M, Kuoppasalmi K, Naveri H, Huhtaniemi I, Tikkanen H, Remes K, Dessypris A, Karvonen J. Effect of training on plasma anabolic and catabolic steroid hormones and their response during physical exercise. Int J Sports Med. 1986 Jun;7 Suppl 1:27-8. doi: 10.1055/s-2008-1025798. No abstract available.
PubMed 3744643Oliver JL, Ramachandran AK, Singh U, Ramirez-Campillo R, Lloyd RS. The Effects of Strength, Plyometric and Combined Training on Strength, Power and Speed Characteristics in High-Level, Highly Trained Male Youth Soccer Players: A Systematic Review and Meta-Analysis. Sports Med. 2024 Mar;54(3):623-643. doi: 10.1007/s40279-023-01944-8. Epub 2023 Oct 28.
PubMed 37897637Aslam S, Habyarimana JD, Bin SY. Neuromuscular adaptations to resistance training in elite versus recreational athletes. Front Physiol. 2025 Jun 9;16:1598149. doi: 10.3389/fphys.2025.1598149. eCollection 2025.
PubMed 40551899Gabbett TJ, Oetter E. From Tissue to System: What Constitutes an Appropriate Response to Loading? Sports Med. 2025 Jan;55(1):17-35. doi: 10.1007/s40279-024-02126-w. Epub 2024 Nov 11.
PubMed 39527327Guo L, Xu P, Li Z, Li Y, Li J, Li S, Lin N, Xu Y. Cistanche total glycoside capsule promotes sperm maturation and fertility by activating the NELL2 Lumicrine pathway in a male reproductive impairment model. J Ethnopharmacol. 2025 Sep 25;353(Pt A):120289. doi: 10.1016/j.jep.2025.120289. Epub 2025 Jul 12.
PubMed 40659143Jiao X, Liu X, Cao Q, Deng Z. Plant-based supplements in enhancing exercise performance and recovery. Front Nutr. 2025 Nov 24;12:1699642. doi: 10.3389/fnut.2025.1699642. eCollection 2025.
PubMed 41368183Naderi A, Rothschild JA, Santos HO, Hamidvand A, Koozehchian MS, Ghazzagh A, Berjisian E, Podlogar T. Nutritional Strategies to Improve Post-exercise Recovery and Subsequent Exercise Performance: A Narrative Review. Sports Med. 2025 Jul;55(7):1559-1577. doi: 10.1007/s40279-025-02213-6. Epub 2025 Apr 12.
PubMed 40221559Tao B, Lian W, Min R, Zhang X, Chen L, Hao S, Li Z, Ma C, Zhang H, Liu C. Effects of Cistanche deserticola Y.C. Ma Supplementation on Muscle Strength and Recovery: A Randomized Controlled Trial. Nutrients. 2025 Sep 16;17(18):2965. doi: 10.3390/nu17182965.
PubMed 41010491Tao J, Zhong X, Lin H, Lai Y, Jian Z, Tao A, Jiang G. The potential, challenges, and prospects of polysaccharides from the genus Cistanche as therapeutic agents for aging-related diseases: A review. Int J Biol Macromol. 2025 Jun;312:144144. doi: 10.1016/j.ijbiomac.2025.144144. Epub 2025 May 11.
PubMed 40360111Varillas-Delgado D. Nutritional Intervention and Ergogenic Aids in Sport Performance and Recovery. Nutrients. 2025 Aug 29;17(17):2806. doi: 10.3390/nu17172806.
PubMed 40944195
Study at a glance
From the registry record, last updated by the sponsor on 21 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Cistanche Supplementation on Anaerobic Exercise Performance and Recovery in Men With Different Athletic Training Levels: A Double-Blind, Randomized, Placebo-Controlled Trial
- ClinicalTrials.gov ID
- NCT07546513
- Acronym / sponsor ID
- 2025161
- Conditions
- Athlete, Elite Athlete, Sport Performance, Exercise Recovery
- Keywords
- Cistanche, anaerobic performance, exercise recovery, explosive power, lactate, muscle damage, body composition, randomized controlled trial
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 56 participants (actual)
- Lead sponsor
- Beijing Sport UniversityUniversity, hospital or other
- Collaborators
- Wuhan Sports University
- Study start
- 25 Jun 2026 (actual)
- Primary completion
- 1 Sep 2026 (actual)
- Study completion
- 15 Sep 2026 (actual)
- First posted
- 22 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is a double-blind, randomized, placebo-controlled trial designed to examine whether 8 weeks of Cistanche deserticola supplementation, when combined with a standardized anaerobic training program, can improve anaerobic exercise performance, recovery, and selected body composition outcomes in young adult men with different athletic training levels.
Participants will be assigned to receive either Cistanche deserticola extract or a matched placebo while completing the same supervised anaerobic training program. The study will assess changes in anaerobic performance, including Wingate test outcomes and jump performance, as well as recovery-related indicators such as blood lactate, creatine kinase, malondialdehyde, testosterone, cortisol, and the testosterone-to-cortisol ratio. Body composition outcomes, including body fat percentage and skeletal muscle mass, will also be evaluated.
The purpose of this study is to determine whether Cistanche deserticola supplementation provides additional benefits beyond training alone, and whether these effects differ between highly trained and recreationally trained participants.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
- Model description
- Model Description
| Arm | Type | Receives |
|---|---|---|
| Cistanche Supplementation + Standardized Anaerobic Training | Experimental | Dietary Supplement: Cistanche deserticola, Behavioral: Standardized anaerobic training programParticipants in this arm receive Cistanche deserticola extract paste (5 g/day) for 8 weeks while completing the same supervised standardized anaerobic training program as the control arm. The training program is performed 3 times per week and includes repeated sprint training, explosive/strength-support exercises, and short-bout high-intensity interval training. |
| Placebo + Standardized Anaerobic Training | Active comparator | Dietary Supplement: Matched placebo paste, Behavioral: Standardized anaerobic training programParticipants in this arm receive a matched placebo for 8 weeks while completing the same supervised standardized anaerobic training program as the experimental arm. The placebo is matched in appearance, weight, texture, and taste. The training program is performed 3 times per week and includes repeated sprint training, explosive/strength-support exercises, and short-bout high-intensity interval training. |
Who may qualify
- Ages
- 18 to 25 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- Male, aged 18 to 25 years
- Body mass index (BMI) between 18.5 and 25.0 kg/m²
- Able and willing to provide written informed consent
- Willing to comply with study procedures, supplementation, training, and assessments
- Belonging to one of the following athletic training strata:
Key exclusion criteria (8 listed)
- Use of steroids or ergogenic supplements during study
- Known cardiovascular, metabolic, musculoskeletal, or other conditions making participation unsafe or affecting outcomes
- Current use of medications affecting muscle growth, recovery, hormones, or high-intensity performance
- Current injury or limitation preventing safe participation
- Known allergy or intolerance to supplement/placebo ingredients
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cistanche deserticolaParticipants receive Cistanche deserticola extract paste at a dose of 5 g/day for 8 weeks. The supplement is administered in two sachets per day, one after breakfast and one after lunch. The product is derived from Cistanche deserticola Y.C. Ma cultivated in Inner Mongolia and consists primarily of phenylethanoid glycosides. Batch-specific quality-control documentation is provided by the supplier to ensure consistency. | Dietary supplement | Cistanche Supplementation + Standardized Anaerobic Training |
| Matched placebo pasteParticipants receive a matched placebo for 8 weeks. The placebo is administered in two sachets per day, one after breakfast and one after lunch, following the same schedule as the experimental supplement. It contains maltodextrin, microcrystalline cellulose, caramel coloring, and a food-grade bittering agent, and is matched to the active supplement in appearance, weight, texture, and taste. | Dietary supplement | Placebo + Standardized Anaerobic Training |
| Standardized anaerobic training programAll participants complete the same supervised standardized anaerobic training program 3 times per week for 8 consecutive weeks. Each session lasts approximately 50 to 65 minutes and includes a dynamic warm-up, repeated sprint training, explosive/strength-support exercises, short-bout high-intensity interval training, and a cool-down. Training load is progressively increased across the intervention period, and attendance as well as session rating of perceived exertion are recorded throughout the study. | Behavioural | Cistanche Supplementation + Standardized Anaerobic Training, Placebo + Standardized Anaerobic Training |
Primary outcome
Peak power during the 30-second Wingate Anaerobic Test
Time frame: Baseline (week 0) and post-intervention (week 8)
Peak power (W) measured during a 30-second Wingate Anaerobic Test performed on a Monark 894E cycle ergometer. The test is conducted under standardized conditions, and the primary analysis will evaluate the change from baseline to post-intervention and the between-group difference in change after 8 weeks of intervention.
Squat jump height
Time frame: Baseline (week 0) and post-intervention (week 8)
Squat jump (SJ) height in centimeters, assessed under standardized testing conditions as a measure of lower-limb explosive performance. Analyses will assess change from baseline to post-intervention and between-group differences in change.
Countermovement jump
Time frame: Baseline (week 0) and post-intervention (week 8)
Countermovement jump (CMJ) height in centimeters, assessed under standardized testing conditions as a measure of lower-limb explosive performance. Analyses will assess change from baseline to post-intervention and between-group differences in change.
10 secondary outcomes
Average power during the 30-second Wingate Anaerobic Test
Time frame: Baseline (week 0) and post-intervention (week 8)
Minimum power during the 30-second Wingate Anaerobic Test
Time frame: Baseline (week 0) and post-intervention (week 8)
Power drop during the 30-second Wingate Anaerobic Test
Time frame: Baseline (week 0) and post-intervention (week 8)
Post-exercise blood lactate response
Time frame: Baseline (week 0) and post-intervention (week 8)
Serum creatine kinase concentration
Time frame: Baseline (week 0) and post-intervention (week 8)
Serum malondialdehyde concentration
Time frame: Baseline (week 0) and post-intervention (week 8)
Serum testosterone concentration
Time frame: Baseline (week 0) and post-intervention (week 8)
Body fat percentage
Time frame: Baseline (week 0) and post-intervention (week 8)
Skeletal muscle mass
Time frame: Baseline (week 0) and post-intervention (week 8)
Serum cortisol concentration
Time frame: Baseline (week 0) and post-intervention (week 8)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Sep 2026.
- Background: PubMed 12900695Bassett DR Jr. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1396. doi: 10.1249/01.MSS.0000078923.96621.1D. No abstract available.
- Background: PubMed 12242311Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci. 2002 Oct;57(10):B359-65. doi: 10.1093/gerona/57.10.b359.
- Background: PubMed 11708692Foster C, Florhaug JA, Franklin J, Gottschall L, Hrovatin LA, Parker S, Doleshal P, Dodge C. A new approach to monitoring exercise training. J Strength Cond Res. 2001 Feb;15(1):109-15.
- Background: PubMed 8933491Bobbert MF, Gerritsen KG, Litjens MC, Van Soest AJ. Why is countermovement jump height greater than squat jump height? Med Sci Sports Exerc. 1996 Nov;28(11):1402-12. doi: 10.1097/00005768-199611000-00009.
- Background: PubMed 1330274Thomas S, Reading J, Shephard RJ. Revision of the Physical Activity Readiness Questionnaire (PAR-Q). Can J Sport Sci. 1992 Dec;17(4):338-45.
- Background: PubMed 3744643Adlercreutz H, Harkonen M, Kuoppasalmi K, Naveri H, Huhtaniemi I, Tikkanen H, Remes K, Dessypris A, Karvonen J. Effect of training on plasma anabolic and catabolic steroid hormones and their response during physical exercise. Int J Sports Med. 1986 Jun;7 Suppl 1:27-8. doi: 10.1055/s-2008-1025798. No abstract available.
- Background: PubMed 37897637Oliver JL, Ramachandran AK, Singh U, Ramirez-Campillo R, Lloyd RS. The Effects of Strength, Plyometric and Combined Training on Strength, Power and Speed Characteristics in High-Level, Highly Trained Male Youth Soccer Players: A Systematic Review and Meta-Analysis. Sports Med. 2024 Mar;54(3):623-643. doi: 10.1007/s40279-023-01944-8. Epub 2023 Oct 28.
- Background: PubMed 40551899Aslam S, Habyarimana JD, Bin SY. Neuromuscular adaptations to resistance training in elite versus recreational athletes. Front Physiol. 2025 Jun 9;16:1598149. doi: 10.3389/fphys.2025.1598149. eCollection 2025.
- Background: PubMed 39527327Gabbett TJ, Oetter E. From Tissue to System: What Constitutes an Appropriate Response to Loading? Sports Med. 2025 Jan;55(1):17-35. doi: 10.1007/s40279-024-02126-w. Epub 2024 Nov 11.
- Background: PubMed 40659143Guo L, Xu P, Li Z, Li Y, Li J, Li S, Lin N, Xu Y. Cistanche total glycoside capsule promotes sperm maturation and fertility by activating the NELL2 Lumicrine pathway in a male reproductive impairment model. J Ethnopharmacol. 2025 Sep 25;353(Pt A):120289. doi: 10.1016/j.jep.2025.120289. Epub 2025 Jul 12.
- Background: PubMed 41368183Jiao X, Liu X, Cao Q, Deng Z. Plant-based supplements in enhancing exercise performance and recovery. Front Nutr. 2025 Nov 24;12:1699642. doi: 10.3389/fnut.2025.1699642. eCollection 2025.
- Background: PubMed 40221559Naderi A, Rothschild JA, Santos HO, Hamidvand A, Koozehchian MS, Ghazzagh A, Berjisian E, Podlogar T. Nutritional Strategies to Improve Post-exercise Recovery and Subsequent Exercise Performance: A Narrative Review. Sports Med. 2025 Jul;55(7):1559-1577. doi: 10.1007/s40279-025-02213-6. Epub 2025 Apr 12.
- Individual participant dataSharing planned: Undecided. The investigators have not yet decided whether individual participant data will be shared. Any future sharing of de-identified data will depend on participant consent, institutional requirements, ethics approval, and data governance considerations.
Related trials for Athlete
Not yet recruitingObservational study
Isokinetic Knee Strength, Bilateral Muscle Balance, and Anaerobic Performance in Adolescent Athletes
Isokinetic Knee Strength, Hamstring-to-Quadriceps Strength Ratio
Recruiting
Feasibility of a Digital Self-help Program for Functional Hypothalamic Amenorrhea (HEAL-FHA Pilot)
Functional Hypothalamic Amenorrhea
Recruiting
Trained vs. Untrained: Lower Extremity Pressure Changes
Trained Athletes, Untrained
Recruiting
Recovery After Fatigue in Young Athletes: Comparison Between TECAR Therapy and Cycle Ergometer"
Muscle Fatigue, Healthy Adult
Not yet recruiting
PLYOMETRIC TRAINING VERSUS CALISTHENIC TECHNIQUE FOR IMPROVING JUMP PERFORMANCE AND PATELLOFEMORAL FUNCTION IN KARATE ATHLETES
Jump Performance, Patellofemoral Joint
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Cistanche deserticola and Standardized anaerobic training program in people with Athlete and Elite Athlete, run by Beijing Sport University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Peak power during the 30-second Wingate Anaerobic Test (time frame: Baseline (week 0) and post-intervention (week 8)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07546513, which also lists 15 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2026.